Washington, United States,
08048034981
Gros 30 mg Injection (5 ml )
HIV AIDS Medicines Exporter India to USA | FDA Approved ARV (antiretroviral) Supplier Leading exporter of HIV/AIDS medicines from India to USA. FDA-compliant antiretroviral (ARV) drugs, WHO-GMP certified manufacturing. Bulk supply for distributors and importers .

Exporter India Gros 30 mg Injection (5 ml ) | Bulk Supply HIV AIDS Medicines.
Buy Exporter India Gros 30 mg Injection (5 ml ) in bulk from India. Leading HIV AIDS Medicines export City Drug House Exporters offering global supply with latest regulatory updates and competitive pricing.

Mechanism of Action: Paclitaxel works by interfering with the normal function of microtubule structures in the cell. It acts as a microtubule stabilizing agent, binding to tubulin, which prevents cancer cells from dividing and multiplying, ultimately leading to cell death.

Administration: It is administered via intravenous infusion by a qualified healthcare professional in a hospital setting.

Common Side Effects: Fatigue, nausea, vomiting, hair loss, peripheral neuropathy, and decreased blood cell counts (neutropenia/infection risk).

Contraindications: Not recommended for patients with severe allergies to paclitaxel, severely low white blood cell counts, or severe liver disease. It should not be used during pregnancy or breastfeeding .

City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics

Contact for More Information :
📞 Contact City drug House Exporters from India

🌐 Websites: https://www.citydrugexporters.com

📧 Email: citydrug123@gmail.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 9975390171





Gros 30 mg Injection (5 ml) is a chemotherapy medicine containing Paclitaxel, a taxane anti-cancer drug. It works by inhibiting the growth and division of cancer cells in ovarian, breast, lung (NSCLC), and AIDS-related Kaposi's sarcoma, often in combination with other agents. It is administered by healthcare professionals.
May 8th, 2026 3:02 PM

Keywords